These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 111489)

  • 1. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro and biological activity in vivo.
    Warren HS; Woolnough JA; Denaro CP; Lafferty KJ
    Adv Exp Med Biol; 1979; 114():757-61. PubMed ID: 111489
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
    Hancock EJ; Kilburn DG
    Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
    Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
    Exp Pathol; 1986; 30(2):65-74. PubMed ID: 3096773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
    Tigelaar RE; Feldmann M
    Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.
    Bertschmann M; Schären B; Lüscher EF
    Immunobiology; 1980 Jan; 156(4-5):382-99. PubMed ID: 6768671
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune responses in vitro: interaction of thymus-derived cells during cytotoxic allograft responses in vitro.
    Wagner H
    Science; 1973 Sep; 181(4105):1170-2. PubMed ID: 4199283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte mediated lysis of tumor cells in the presence of alloantiserum.
    Liepins A; Faanes RB; Choi YS; de Harven E
    Cell Immunol; 1978 Mar; 36(2):331-44. PubMed ID: 415815
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of lymphocyte-mediated cytolysis. X. Enucleated cells as targets for cytotoxic attack.
    Siliciano RF; Henney CS
    J Immunol; 1978 Jul; 121(1):186-91. PubMed ID: 97346
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
    Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
    Arch Geschwulstforsch; 1987; 57(1):7-15. PubMed ID: 3105513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.
    Maier T; Levy JG; Kilburn DG
    Cell Immunol; 1980 Dec; 56(2):392-9. PubMed ID: 6451300
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of BCG action. I. The induction of nonspecific helper cells during the potentiation of alloimmune cell-mediated cytotoxic responses.
    Davies M; Sabbadini E
    Cancer Immunol Immunother; 1982; 14(1):46-53. PubMed ID: 6218872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.